Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.48 |
| ▸ | MITF | O75030 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | PREP | P48147 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | HTR2C | P28335 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CASP1 | P29466 | 1/20 | 0.43 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.42 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.42 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.42 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.42 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.42 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4849092 | 1.00 | HTT (0.48) | HTTMITFMAPTFKBP1ANPSR1 | |
| SCHEMBL10741414 | 0.90 | NPC1 (0.46) | NPSR1PREPSMN1; SMN2NPC1RAB9A | |
| SCHEMBL12820199 | 0.89 | MITF (0.43) | HTTMITFMAPTFKBP1ANPSR1 | |
| SCHEMBL18020339 | 0.87 | MITF (0.49) | HTTMITFMAPTFKBP1ANPSR1 | |
| SCHEMBL2707991 | 0.86 | MITF (0.48) | HTTMITFMAPTFKBP1ANPSR1 | |
| SCHEMBL204603 | 0.86 | MITF (0.48) | HTTMITFMAPTFKBP1ANPSR1 | |
| SCHEMBL8298601 | 0.86 | MITF (0.48) | HTTMITFMAPTFKBP1ANPSR1 | |
| SCHEMBL8279227 | 0.86 | MITF (0.48) | HTTMITFMAPTFKBP1ANPSR1 | |
| SCHEMBL201195 | 0.84 | HTT (0.47) | HTTMITFMAPTFKBP1ANPSR1 | |
| SCHEMBL9977347 | 0.84 | HTT (0.47) | HTTMITFMAPTFKBP1ANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9814699-B2 | Chemical compounds | Janssen Pharmaceuticals, Inc. (US) | 2017-11-14 | — | — | US | disclosed |
| US-20160158201-A1 | CHEMICAL COMPOUNDS | JANSSEN PHARMACEUTICALS INC (US) | 2016-06-09 | — | — | US | disclosed |
| US-20150374668-A1 | CHEMICAL COMPOUNDS | JANSSEN PHARMACEUTICALS INC (US) | 2015-12-31 | — | — | US | disclosed |
| US-9150587-B2 | Chemical compounds | Janssen Pharmaceuticals, Inc. (US) | 2015-10-06 | — | — | US | disclosed |
| US-20140371455-A1 | Chemical compounds | JANSSEN PHARMACEUTICALS INC (US) | 2014-12-18 | — | — | US | disclosed |
| US-8853416-B2 | Chemical compounds | Janssen Pharmaceuticals, Inc. (US) | 2014-10-07 | — | — | US | disclosed |
| US-20130274304-A1 | Chemical Compounds | Janssen Pharmaceuticals, Inc. | 2013-10-17 | — | — | US | disclosed |
| US-8492554-B2 | Chemical compounds | GLAXOSMITHKLINE LLC (US) | 2013-07-23 | — | — | US | disclosed |
| US-20130072690-A1 | Chemical Compounds | GLAXOSMITHKLINE LLC (US) | 2013-03-21 | — | — | US | disclosed |
| US-8344155-B2 | Chemical compounds | GLAXOSMITH KLINE LLC (US) | 2013-01-01 | — | — | US | disclosed |
| US-20110152237-A1 | Chemical Compounds | GLAXOSMITHKLINE LLC | 2011-06-23 | — | — | US | disclosed |
| US-7342012-B2 | Inhibitors of αLβ2 mediated cell adhesion | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2008-03-11 | — | — | US | disclosed |
| US-20050148602-A1 | Inhibitors of alphaLbeta2 mediated cell adhesion | TANABE SEIYAKU CO., LTD. | 2005-07-07 | — | — | US | disclosed |
| US-6897225-B1 | Inhibitors of αLβ2 mediated cell adhesion | TANABE SEIYAKU CO., LTD. (JP) | 2005-05-24 | — | — | US | disclosed |
| EP-1307455-B1 | INHIBITORS OF ALPHA-L BETA-2 MEDIATED CELL ADHESION | TANABE SEIYAKU CO (JP) | 2005-04-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150374668-A1 | CHEMICAL COMPOUNDS | SLC10A1, UGT1A3, UGT2B7 | HTT 2768/4885MITF 2954/4885MAPT 2480/4885 |
| US-20160158201-A1 | CHEMICAL COMPOUNDS | SLC10A1, UGT1A3, UGT2B7 | HTT 2768/4885MITF 2954/4885MAPT 2480/4885 |
| US-20140371455-A1 | Chemical compounds | SLC10A1, UGT1A3, UGT2B7 | HTT 2768/4885MITF 2954/4885MAPT 2480/4885 |
| US-20130072690-A1 | Chemical Compounds | SLC10A1, UGT1A3, UGT2B7 | HTT 2768/4885MITF 2954/4885MAPT 2480/4885 |
| US-20130274304-A1 | Chemical Compounds | SLC10A1, UGT1A3, UGT2B7 | HTT 2768/4885MITF 2954/4885MAPT 2480/4885 |
| US-20110152237-A1 | Chemical Compounds | SLC10A1, UGT1A3, UGT2B7 | HTT 2768/4885MITF 2954/4885MAPT 2480/4885 |
| US-20050148602-A1 | Inhibitors of alphaLbeta2 mediated cell adhesion | ITGB2, ITGA2B, ITGB1 | HTT 4603/4885MITF 3629/4885MAPT 2995/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.